European Society of Contact Dermatitis guideline for diagnostic patch testing - Recommendations on best practice

Contact Dermatitis

Volumn 73, Issue 4, 2015, Pages 195-221

  Johansen, Jeanne D ^a   Aalto Korte, Kristiina ^b   Agner, Tove ^a   Andersen, Klaus E ^c   Bircher, Andreas ^d   Bruze, Magnus ^e   Cannavõ, Alicia ^f   Giménez Arnau, Ana ^g   Gonçalo, Margarida ^h   Goossens, An ⁱ   John, Swen M ^j   Lidén, Carola ^k   Lindberg, Magnus ^l   Mahler, Vera ^m   Matura, Mihály ⁿ   Rustemeyer, Thomas ^o   Serup, Jørgen ^a   Spiewak, Radoslaw ^p   Thyssen, Jacob P ^a   Vigan, Martine ^q   White, Ian R ^r   Wilkinson, Mark ^s   Uter, Wolfgang ^t   more..

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

^c ODENSE UNIVERSITY HOSPITAL   (Denmark)

^d UNIVERSITY HOSPITAL BASEL   (Switzerland)

^e LUND UNIVERSITY HOSPITAL   (Sweden)

^f Hospital Bernardo Houssay in northern Buenos Aires   (Argentina)

^g UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^h CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

ⁱ UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^j UNIVERSITY OF OSNABRÜCK   (Germany)

^k KAROLINSKA INSTITUTE   (Sweden)

^l ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^m UNIVERSITY HOSPITAL ERLANGEN   (Germany)

ⁿ SLSO   (Sweden)

^o VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^p JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^q UNIVERSITY HOSPITAL OF BESANÇON   (France)

^r ST THOMAS HOSPITAL   (United Kingdom)

^s Spire Hospital   (United Kingdom)

^t UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

more..

Author keywords

contact allergy; guideline; patch testing; review

Indexed keywords

ALLERGEN;

ADVERSE OUTCOME; ARTICLE; ATOPIC DERMATITIS; CLINICAL PRACTICE; CONTACT ALLERGY; CONTACT DERMATITIS; CONTACT URTICARIA; DELAYED HYPERSENSITIVITY; DERMATOLOGIST; DRUG ERUPTION; ECZEMA; ERYTHEMA; HUMAN; HYPERPIGMENTATION; HYPOPIGMENTATION; IMMEDIATE TYPE HYPERSENSITIVITY; IMMUNOSUPPRESSIVE TREATMENT; LABORATORY DIAGNOSIS; LACTATION; MEDICAL EDUCATION; MEDICAL SOCIETY; NECROSIS; OCCUPATIONAL ECZEMA; OCCUPATIONAL EXPOSURE; PAPULE; PATCH TEST; PATIENT EDUCATION; PHOTOPATCH TEST; PRACTICE GUIDELINE; PREGNANCY; RADIATION EXPOSURE; SCAR FORMATION; SKIN ALLERGY; SKIN SENSITIVITY; SUN EXPOSURE; ULTRAVIOLET RADIATION; ADULT; ADVERSE EFFECTS; CHILD; DERMATITIS, ALLERGIC CONTACT; DERMATITIS, OCCUPATIONAL; DRUG ERUPTIONS; HYPERSENSITIVITY, DELAYED; PROCEDURES;

ADULT; ALLERGENS; CHILD; DERMATITIS, ALLERGIC CONTACT; DERMATITIS, OCCUPATIONAL; DRUG ERUPTIONS; HUMANS; HYPERSENSITIVITY, DELAYED; PATCH TESTS; PATIENT EDUCATION AS TOPIC;

EID: 84936848475     PISSN: 01051873     EISSN: 16000536     Source Type: Journal    
DOI: 10.1111/cod.12432     Document Type: Article

References (166)

1. Lachapelle J M, Maibach H,. Patch Testing, Prick Testing - a Practical Guide: Berlin, Heidelberg, Springer, 2009.
2. Rietschel R, Fowler J,. Fisher's Contact Dermatitis: Lewiston, ME, BC Dekker, 2008.
3. Johansen, J. D.,;, Frosch, P. J., &, Lepoittevin, J.-P., (eds). 2011, Contact Dermatitis. Springer, Berlin, Heidelberg.
4. Johansen J D, Thyssen J, Lepoittevin J-P, (Eds). Quick Guide to Contact Dermatitis: Berlin, Heidelberg, Springer, 2015. (in press).
5. Rustemeyer T, Elsner P, John S M, Maibach H, (Eds). Kanerva's Occupational Dermatology: Heidelberg, New York, Dordrecht, London, Springer, 2012.
6. Lindberg M, Matura M,. Patch testing. In: Contact Dermatitis, 5th edition, Johansen, J. D.,;, Frosch, P. J., &, Lepoittevin, J.-P., (Eds): Heidelberg, Dordrecht, London, New York, Springer, 2011: 439-464.
7. Goon A, Gook C-L,. Non-eczematous contact reactions. In: Contact Dermatitis, 5th edition, Johansen, J. D.,;, Frosch, P. J., &, Lepoittevin, J.-P., (Eds): Heidelberg, Dordrecht, London, New York, Springer, 2011: 415-427.
8. Goncalo M, Bruynzeel D,. Patch testing in adverse drug reactions. In: Contact Dermatitis, 5th edition, Johansen, J. D.,;, Frosch, P. J., &, Lepoittevin, J.-P., (Eds): Heidelberg, Dordrecht, London, New York, Springer, 2011: 475-491.
9. Isakson M,. Dental materials. In: Contact Dermatitis, 5th edition, Johansen, J. D.,;, Frosch, P. J., &, Lepoittevin, J.-P., (Eds): Heidelberg, Dordrecht, London, New York, Springer, 2011: 763-791.
10. Schalock P C, Menné T, Johansen J D, Taylor J S, Maibach H I, Lidén C, Bruze M, Thyssen J P,. Hypersensitivity reactions to metallic implants - diagnostic algorithm and suggested patch test series for clinical use. Contact Dermatitis 2012: 66: 4-19.
11. Svedman C, Ekqvist S, Möller H, et al., A correlation found between contact allergy to stent material and restenosis of the coronary arteries. Contact Dermatitis 2009: 60: 158-164.
12. Perfetti L, Galdi E, Biale C, Garbelli N, Moscato G,. Anaphylactoid reaction to patch testing with ammonium persulfate. Allergy 2000: 55: 94-95.
13. Green C,. The effect of topically applied corticosteroid on irritant and allergic patch test reactions. Contact Dermatitis 1996: 35: 331-333.
14. Ring J,. Angewandte Allergologie: München, MMW Medizinverlag, 1991.
15. Fischer T, Maibach H,. Finn chamber patch test technique. Contact Dermatitis 1984: 11: 137-140.
16. Cronin E,. Clinical prediction of patch test results. Trans St Johns Hosp Dermatol Soc 1972: 58: 153-162.
17. Podmore P, Burrows D, Bingham E A,. Prediction of patch test results. Contact Dermatitis 1984: 11: 283-284.
18. Bruynzeel D P, Andersen K E, Camarasa J G, Lachapelle J M, Menné T, White I R,. The European standard series. European Environmental and Contact Dermatitis Research Group (EECDRG). Contact Dermatitis 1995: 33: 145-148.
19. Bruze M, Condé-Salazar L, Goossens A, Kanerva L, White I R,. Thoughts on sensitizers in a standard patch test series. The European Society of Contact Dermatitis. Contact Dermatitis 1999: 41: 241-250.
20. Bruze M, Goossens A, Isaksson M,. Recommendation to increase the test concentration of methylchloroisothiazolinone/methylisothiazolinone in the European baseline patch test series0.167em-0.167emon behalf of the European Society of Contact Dermatitis and the European Environmental and Contact Dermatitis Research Group. Contact Dermatitis 2014: 71: 35-40.
21. Isakson M, Ryberg K, Goossens A, Bruze M,. Recommendation to include a textile dye mix into the European baseline series (On behalf of the European Society of Contact Dermatitis and the European Environmental and Contact Dermatitis Research Group). Contact Dermatitis 2015: 73: 15-20.
22. Jensen C D, Paulsen E, Andersen K E,. Retrospective evaluation of the consequence of alleged patch test sensitization. Contact Dermatitis 2006: 55: 30-35.
23. Krautheim A, Lessmann H, Geier J,. Patch testing with patient's own materials handled at work. In: Kanerva's Occupational Dermatology, 2nd edition, Rustemeyer, T.,;, Elsner, P.,;, John, S. M., &, Maibach, H., (Eds): Heidelberg etc., Springer, 2012: 919-934.
24. Frosch P, Geier J, Uter W, Goossens A,. Patch testing with the patients' own products. In: Contact Dermatitis, 5th edition, Johansen, J. D.,;, Frosch, P. J., &, Lepoittevin, J.-P., (Eds): Berlin, Heidelberg, Springer, 2011: 1107-1120.
25. de Groot A,. Patch Testing. Test Concentrations and Vehicles for 4350 Chemicals: Wapserveen, Acdegroot Publishing, 2008.
26. Goon A T J, Bruze M, Zimerson E, Sörensen Ö, Goh C L, Koh D S Q, Isaksson M,. Variation in allergen content over time of acrylates/methacrylates in patch test preparations. Br J Dermatol 2011: 164: 116-124.
27. Mose K F, Andersen K E, Christensen L P,. Stability of selected volatile contact allergens in different patch test chambers under different storage conditions. Contact Dermatitis 2012: 66: 172-179.
28. Mowitz M, Svedman C, Zimerson E, Bruze M,. Fragrance patch tests prepared in advance may give false-negative reactions. Contact Dermatitis 2014: 71: 289-294.
29. Joy N M, Rice K R, Atwater A R,. Stability of patch test allergens. Dermatitis 2013: 24: 227-236.
30. Siegel P D, Fowler J F, Law B F, Warshaw E M, Taylor J S,. Concentrations and stability of methyl methacrylate, glutaraldehyde, formaldehyde and nickel sulfate in commercial patch test allergen preparations. Contact Dermatitis 2014: 70: 309-315.
31. Friedmann P S,. Contact sensitisation and allergic contact dermatitis: immunobiological mechanisms. Toxicol Lett 2006: 162: 49-54.
32. Frosch P J, Kligman A M,. The Duhring chamber. An improved technique for epicutaneous testing of irritant and allergic reactions. Contact Dermatitis 1979: 5: 73-81.
33. Fischer T, Maibach H,. Amount of nickel applied with a standard patch test. Contact Dermatitis 1984: 11: 285-287.
34. Svedman C, Isaksson M, Björk J, Mowitz M, Bruze M,. 'Calibration' of our patch test reading technique is necessary. Contact Dermatitis 2012: 66: 180-187.
35. Bruze M, Isaksson M, Gruvberger B, Frick-Engfeldt M,. Recommendation of appropriate amounts of petrolatum preparation to be applied at patch testing. Contact Dermatitis 2007: 56: 281-285.
36. Frick-Engfeldt M, Gruvberger B, Isaksson M, Hauksson I, Pontén A, Bruze M,. Comparison of three different techniques for application of water solutions to Finn Chambers®. Contact Dermatitis 2010: 63: 284-288.
37. Bruze M, Fregert S,. Studies on purity and stability of photopatch test substances. Contact Dermatitis 1983: 9: 33-39.
38. Isaksson M, Gruvberger B, Persson L, Bruze M,. Stability of corticosteroid patch test preparations. Contact Dermatitis 2000: 42: 144-148.
39. Mowitz M, Zimerson E, Svedman C, Bruze M,. Stability of fragrance patch test preparations applied in test chambers. Br J Dermatol 2012: 167: 822-827.
40. Moffitt D L, Sharp L A, Sansom J E,. Audit of Finn Chamber patch test preparation. Contact Dermatitis 2002: 47: 334-336.
41. Bruze M, Frick-Engfeldt M, Gruvberger B, Isaksson M,. Variation in the amount of petrolatum preparation applied at patch testing. Contact Dermatitis 2007: 56: 38-42.
42. Bruze M, Svedman C,. Patch testing. In: Quick Guide to Contact Dermatitis, Johansen J D, Thyssen J, Lepoittevin J-P, (eds): Berlin, Heidelberg, Springer, 2015 (in press).
43. Memon A A, Friedmann P S,. Studies on the reproducibility of allergic contact dermatitis. Br J Dermatol 1996: 134: 208-214.
44. Hannuksela M,. Sensitivity of various skin sites in the repeated open application test. Am J Contact Dermat 1991: 2: 102-104.
45. van Strien G A, Korstanje M J,. Site variations in patch test responses on the back. Contact Dermatitis 1994: 31: 95-96.
46. Simonetti V, Manzini B M, Seidenari S,. Patch testing with nickel sulfate: comparison between 2 nickel sulfate preparations and 2 different test sites on the back. Contact Dermatitis 1998: 39: 187-191.
47. 2. Contact Dermatitis 1984: 10: 25-29.
48. Bruze M,. Patch testing with nickel sulphate under occlusion for five hours. Acta Derm Venereol 1988: 68: 361-364.
49. Isaksson M, Bruze M, Goossens A, Lepoittevin J P,. Patch testing with budesonide in serial dilutions: the significance of dose, occlusion time and reading time. Contact Dermatitis 1999: 40: 24-31.
50. Friedmann P S, Moss C, Shuster S, Simpson J M,. Quantitative relationships between sensitizing dose of DNCB and reactivity in normal subjects. Clin Exp Immunol 1983: 53: 709-715.
51. Manuskiatti W, Maibach H I,. 1- versus 2- and 3-day diagnostic patch testing. Contact Dermatitis 1996: 35: 197-200.
52. Brasch J, Geier J, Henseler T,. Evaluation of patch test results by use of the reaction index. An analysis of data recorded by the Information Network of Departments of Dermatology (IVDK). Contact Dermatitis 1995: 33: 375-380.
53. Fregert S,. Manual of Contact Dermatitis: Copenhagen, Munksgaard, 1974.
54. Hillen U, Jappe U, Frosch P J, et al., Late reactions to the patch-test preparations para-phenylenediamine and epoxy resin: a prospective multicentre investigation of the German Contact Dermatitis Research Group. Br J Dermatol 2006: 154: 665-670.
55. Hextall J M, Alagaratnam N J, Glendinning A K, Holloway D B, Blaikie L, Basketter D A, McFadden J P,. Dose-time relationships for elicitation of contact allergy to para-phenylenediamine. Contact Dermatitis 2002: 47: 96-99.
56. Marmgren V, Hindsén M, Zimerson E, Bruze M,. Successful photopatch testing with ketoprofen using one-hour occlusion. Acta Derm Venereol 2011: 91: 131-136.
57. Magnusson B, Blohm S G, Fregert S, Hjorth N, Hovding G, Pirilä V, Skog E,. Routine patch testing. II. Proposed basic series of test substances for Scandinavian countries and general remarks on testing technique. Acta Derm Venereol 1966: 46: 153-158.
58. Schnuch A, Aberer W, Agathos M, et al., Performing patch testing with contact allergens. J Dtsch Dermatol Ges 2008: 6: 770-775.
59. Bourke J, Coulson I, English J,. Guidelines for the management of contact dermatitis: an update. Br J Dermatol 2009: 160: 946-954.
60. Johansen J, Menné T, Christophersen J, Kaaber K, Veien N,. Changes in the pattern of sensitization to common contact allergens in Denmark between 1985-1986 and 1997-1998, with a special view to the effect of preventive strategies. Br J Dermatol 2000: 142: 490-495.
61. Svedman C, Andersen K E, Brandão F M, et al., Follow-up of the monitored levels of preservative sensitivity in Europe: overview of the years 2001-2008. Contact Dermatitis 2012: 67: 312-314.
62. Macfarlane A W, Curley R K, Graham R M, Lewis-Jones M S, King C M,. Delayed patch test reactions at days 7 and 9. Contact Dermatitis 1989: 20: 127-132.
63. Jonker M J, Bruynzeel D P,. The outcome of an additional patch-test reading on days 6 or 7. Contact Dermatitis 2000: 42: 330-335.
64. Isaksson M, Andersen K E, Brandão F M, et al., Patch testing with corticosteroid mixes in Europe. A multicentre study of the EECDRG. Contact Dermatitis 2000: 42: 27-35.
65. Uter W J, Geier J, Schnuch A,. Good clinical practice in patch testing: readings beyond day 2 are necessary: a confirmatory analysis. Members of the Information Network of Departments of Dermatology. Am J Contact Dermat 1996: 7: 231-237.
66. Andersen K E, Andersen F,. The reaction index and positivity ratio revisited. Contact Dermatitis 2008: 58: 28-31.
67. Bernedo N, González I, Gastaminza G, Audicana M, Fernández E, Muñoz D,. Positive patch test in vancomycin allergy. Contact Dermatitis 2001: 45: 43.
68. Nosbaum A, Vocanson M, Rozieres A, Hennino A, Nicolas J-F,. Allergic and irritant contact dermatitis. Eur J Dermatol 2009: 19: 325-332.
69. Geier J, Uter W, Lessmann H, Schnuch A,. The positivity ratio - another parameter to assess the diagnostic quality of a patch test preparation. Contact Dermatitis 2003: 48: 280-282.
70. Brasch J, Henseler T,. The reaction index: a parameter to assess the quality of patch test preparations. Contact Dermatitis 1992: 27: 203-204.
71. Brasch J, Geier J,. How to use the reaction index and positivity ratio. Contact Dermatitis 2008: 59: 63-65.
72. Löffler H, Becker D, Brasch J, Geier J,. Simultaneous sodium lauryl sulphate testing improves the diagnostic validity of allergic patch tests. Results from a prospective multicentre study of the German Contact Dermatitis Research Group (Deutsche Kontaktallergie-Gruppe, DKG). Br J Dermatol 2005: 152: 709-719.
73. Hannuksela M, Salo H,. The repeated open application test (ROAT). Contact Dermatitis 1986: 14: 221-227.
74. Johansen J D, Bruze M, Andersen K E, et al., The repeated open application test: suggestions for a scale of evaluation. Contact Dermatitis 1998: 39: 95-96.
75. Johansen J D, Frosch P J, Svedman C, Andersen K E, Bruze M, Pirker C, Menné T,. Hydroxyisohexyl 3-cyclohexene carboxaldehyde - known as Lyral: quantitative aspects and risk assessment of an important fragrance allergen. Contact Dermatitis 2003: 48: 310-316.
76. Goossens A,. Alternatives aux patch-tests. Ann Dermatol Venereol 2009: 136: 623-625.
77. Bruynzeel D P, Ferguson J, Andersen K, et al., Photopatch testing: a consensus methodology for Europe. J Eur Acad Dermatol Venereol 2004: 18: 679-682.
78. Batchelor R J, Wilkinson S M,. Photopatch testing - a retrospective review using the 1 day and 2 day irradiation protocols. Contact Dermatitis 2006: 54: 75-78.
79. Gonçalo M, Ferguson J, Bonevalle A, et al., Photopatch testing: recommendations for a European photopatch test baseline series. Contact Dermatitis 2013: 68: 239-243.
80. Gonçalo M,. Photopatch testing. In: Contact Dermatitis, 5th edition, Johansen, J. D.,;, Frosch, P. J., &, Lepoittevin, J.-P., (Eds): Heidelberg, Dordrecht, London, New York, Springer, 2011: 519-544.
81. Hausen B,. Woods Injurious to Human Health: Berlin, De Gruyter, 1981.
82. LeCoz C, Ducombs G, Paulsen E,. Plants and plant products. In: Contact Dermatitis, 5th edition, Johansen, J. D.,;, Frosch, P. J., &, Lepoittevin, J.-P., (Eds): Heidelberg, Dordrecht, London, New York, Springer, 2011: 873-925.
83. Bruze M,. Use of buffer solutions for patch testing. Contact Dermatitis 1984: 10: 267-269.
84. Bruze M, Trulsson L, Bendsöe N,. Patch testing with ultra-sonic bath extracts. Am J Contact Dermat 1992: 3: 133-137.
85. Bruze M, Frick M, Persson L,. Patch testing with thin-layer chromatograms. Contact Dermatitis 2003: 48: 278-279.
86. Bruze M,. What is a relevant contact allergy? Contact Dermatitis 1990: 23: 224-225.
87. Benezra C, Maibach H,. True cross-sensitization, false cross-sensitization and otherwise. Contact Dermatitis 1984: 11: 65-69.
88. Lachapelle J M,. A proposed relevance scoring system for positive allergic patch test reactions: practical implications and limitations. Contact Dermatitis 1997: 36: 39-43.
89. Fransway A F, Zug K A, Belsito D V, et al., North American Contact Dermatitis Group patch test results for 2007-2008. Dermatitis 2013: 24: 10-21.
90. Heisterberg M V, Menné T, Johansen J D,. Contact allergy to the 26 specific fragrance ingredients to be declared on cosmetic products in accordance with the EU cosmetics directive. Contact Dermatitis 2011: 65: 266-275.
91. Frosch P J, Pirker C, Rastogi S C, et al., Patch testing with a new fragrance mix detects additional patients sensitive to perfumes and missed by the current fragrance mix. Contact Dermatitis 2005: 52: 207-215.
92. Thyssen J P, Skare L, Lundgren L, Menné T, Johansen J D, Maibach H I, Lidén C,. Sensitivity and specificity of the nickel spot (dimethylglyoxime) test. Contact Dermatitis 2010: 62: 279-288.
93. Julander A, Skare L, Vahter M, Lidén C,. Nickel deposited on the skin - visualization by DMG test. Contact Dermatitis 2011: 64: 151-157.
94. Thyssen J P, Menné T, Johansen J D, Lidén C, Julander A, Møller P, Jellesen M S,. A spot test for detection of cobalt release - early experience and findings. Contact Dermatitis 2010: 63: 63-69.
95. Thyssen J P, Johansen J D, Jellesen M S, Møller P, Sloth J J, Zachariae C, Menné T,. Consumer leather exposure: an unrecognized cause of cobalt sensitization. Contact Dermatitis 2013: 69: 276-279.
96. Midander K, Julander A, Skare L, Thyssen J P, Lidén C,. The cobalt spot test - further insights into its performance and use. Contact Dermatitis 2013: 69: 280-287.
97. Kettelarij J A B, Lidén C, Axén E, Julander A,. Cobalt, nickel and chromium release from dental tools and alloys. Contact Dermatitis 2014: 70: 3-10.
98. Hauksson I, Pontén A, Gruvberger B, Isaksson M, Bruze M,. Clinically relevant contact allergy to formaldehyde may be missed by testing with formaldehyde 1%. Br J Dermatol 2011: 164: 568-572.
99. Gruvberger B, Bruze M, Fregert S, Lidén C,. Allergens exposure assessment. In: Contact Dermatitis, 5th edition, Johansen, J. D.,;, Frosch, P. J., &, Lepoittevin, J.-P., (Eds): Heidelberg, Dordrecht, London, New York, Springer, 2011: 493-510.
100. Fischer L A, Voelund A, Andersen K E, Menné T, Johansen J D,. The dose-response relationship between the patch test and ROAT and the potential use for regulatory purposes. Contact Dermatitis 2009: 61: 201-208.
101. Wilkinson D S, Fregert S, Magnusson B, et al., Terminology of contact dermatitis. Acta Derm Venereol 1970: 50: 287-292.
102. Dickel H, Kreft B, Kuss O, et al. Increased sensitivity of patch testing by standardized tape stripping beforehand: a multicentre diagnostic accuracy study. Contact Dermatitis 2010: 62: 294-302.
103. Wee J S, White J M L, McFadden J P, White I R,. Patch testing in patients treated with systemic immunosuppression and cytokine inhibitors. Contact Dermatitis 2010: 62: 165-169.
104. Anveden I, Lindberg M, Andersen K E, et al., Oral prednisone suppresses allergic but not irritant patch test reactions in individuals hypersensitive to nickel. Contact Dermatitis 2004: 50: 298-303.
105. Feuerman E, Levy A,. A study of the effect of prednisone and an antihistamine on patch test reactions. Br J Dermatol 1972: 86: 68-71.
106. Ulff E, Maroti M, Serup J,. Fluorescent cream used as an educational intervention to improve the effectiveness of self-application by patients with atopic dermatitis. J Dermatolog Treat 2013: 24: 268-271.
107. Johnson M W, Maibach H I, Salmon S E,. Brief communication: quantitative impairment of primary inflammatory response in patients with cancer. J Natl Cancer Inst 1973: 51: 1075-1076.
108. van der Harst-Oostveen C J, van Vloten W A,. Delayed-type hypersensitivity in patients with mycosis fungoides. Dermatologica 1978: 157: 129-135.
109. Grossman J, Baum J, Gluckman J, Fusner J, Condemi J J,. The effect of aging and acute illness on delayed hypersensitivity. J Allergy Clin Immunol 1975: 55: 268-275.
110. Cooper K D, Oberhelman L, Hamilton T A, Baadsgaard O, Terhune M, LeVee G, Anderson T, Koren H,. UV exposure reduces immunization rates and promotes tolerance to epicutaneous antigens in humans: relationship to dose, CD1a-DR+ epidermal macrophage induction, and Langerhans cell depletion. Proc Natl Acad Sci USA 1992: 89: 8497-8501.
111. Skov L, Hansen H, Barker J N, Simon J C, Baadsgaard O,. Contrasting effects of ultraviolet-A and ultraviolet-B exposure on induction of contact sensitivity in human skin. Clin Exp Immunol 1997: 107: 585-588.
112. Thorvaldsen J, Volden G,. PUVA-induced diminution of contact allergic and irritant skin reactions. Clin Exp Dermatol 1980: 5: 43-46.
113. Seité S, Zucchi H, Moyal D, Tison S, Compan D, Christiaens F, Gueniche A, Fourtanier A,. Alterations in human epidermal Langerhans cells by ultraviolet radiation: quantitative and morphological study. Br J Dermatol 2003: 148: 291-299.
114. Uter W,. Allergic contact dermatitis. In: Filaggrin Molecules in Health and Disease, Thyssen, J., &, Maibach, H., (Eds): Berlin, Heidelberg, New York, Springer, 2014: 251-257.
115. Thyssen J P, Linneberg A, Ross-Hansen K, et al., Filaggrin mutations are strongly associated with contact sensitization in individuals with dermatitis. Contact Dermatitis 2013: 68: 273-276.
116. Simonsen A B, Deleuran M, Mortz C G, Johansen J D, Sommerlund M,. Allergic contact dermatitis in Danish children referred for patch testing - a nationwide multicentre study. Contact Dermatitis 2014: 70: 104-111.
117. Schena D, Papagrigoraki A, Tessari G, Peroni A, Sabbadini C, Girolomoni G,. Allergic contact dermatitis in children with and without atopic dermatitis. Dermatitis 2012: 23: 275-280.
118. Netterlid E, Hindsén M, Ekqvist S, Henricson K A, Bruze M,. Young individuals with atopic disease and asthma or rhinoconjunctivitis may have clinically relevant contact allergies. Dermatitis 2014: 25: 115-119.
119. Moustafa M, Holden C R, Athavale P, Cork M J, Messenger A G, Gawkrodger D J,. Patch testing is a useful investigation in children with eczema. Contact Dermatitis 2011: 65: 208-212.
120. Morren M-A, Goossens A,. Contact allergy in children. In: Contact Dermatitis, 5th edition, Johansen J D, Frosch P J, Lepoittevin J-P, (eds): Heidelberg, Dordrecht, London, New York, Springer, 2011: pp. 937-961.
121. Spornraft-Ragaller P, Schnuch A, Uter W,. Extreme patch test reactivity to p-phenylenediamine but not to other allergens in children. Contact Dermatitis 2011: 65: 220-226.
122. Friis U F, Menné T, Flyvholm M-A, Bonde J P E, Johansen J D,. Occupational allergic contact dermatitis diagnosed by a systematic stepwise exposure assessment of allergens in the work environment. Contact Dermatitis 2013: 69: 153-163.
123. Schwensen J F, Lundov M D, Bossi R, et al., Methylisothiazolinone and benzisothiazolinone are widely used in paint: a multicentre study of paints from five European countries. Contact Dermatitis 2015: 72: 127-138.
124. Santiago F, Gonçalo M, Vieira R, Coelho S, Figueiredo A,. Epicutaneous patch testing in drug hypersensitivity syndrome (DRESS). Contact Dermatitis 2010: 62: 47-53.
125. Barbaud A,. Skin testing and patch testing in non-IgE-mediated drug allergy. Curr Allergy Asthma Rep 2014: 14: 442.
126. Andrade P, Brinca A, Gonçalo M,. Patch testing in fixed drug eruptions - a 20-year review. Contact Dermatitis 2011: 65: 195-201.
127. Serra D, Ramos L, Brinca A, Gonçalo M,. Acute generalized exanthematous pustulosis associated with acyclovir, confirmed by patch testing. Dermatitis 2012: 23: 99-100.
128. Barbaud A, Gonçalo M, Bruynzeel D, Bircher A,. Guidelines for performing skin tests with drugs in the investigation of cutaneous adverse drug reactions. Contact Dermatitis 2001: 45: 321-328.
129. Brockow K, Garvey L H, Aberer W, et al., Skin test concentrations for systemically administered drugs - an ENDA/EAACI Drug Allergy Interest Group position paper. Allergy 2013: 68: 702-712.
130. Barbaud A, Collet E, Milpied B, et al., A multicentre study to determine the value and safety of drug patch tests for the three main classes of severe cutaneous adverse drug reactions. Br J Dermatol 2013: 168: 555-562.
131. Barbaud A, Trechot P, Weber-Muller F, Ulrich G, Commun N, Schmutz J L,. Drug skin tests in cutaneous adverse drug reactions to pristinamycin: 29 cases with a study of cross-reactions between synergistins. Contact Dermatitis 2004: 50: 22-26.
132. Pirker C, Misic A, Brinkmeier T, Frosch P J,. Tetrazepam drug sensitivity - usefulness of the patch test. Contact Dermatitis 2002: 47: 135-138.
133. Romano A, Caubet J-C,. Antibiotic allergies in children and adults: from clinical symptoms to skin testing diagnosis. J Allergy Clin Immunol Pract 2014: 2: 3-12.
134. Pereira N, Canelas M M, Santiago F, Brites M M, Gonçalo M,. Value of patch tests in clindamycin-related drug eruptions. Contact Dermatitis 2011: 65: 202-207.
135. Brajon D, Menetre S, Waton J, Poreaux C, Barbaud A,. Non-irritant concentrations and amounts of active ingredient in drug patch tests. Contact Dermatitis 2014: 71: 170-175.
136. Hillen U, Frosch P J, John S M, Pirker C, Wundenberg J, Goos M,. Patch test sensitization caused by para-tertiary-butylcatechol. Results of a prospective study with a dilution series. Contact Dermatitis 2001: 45: 193-196.
137. Bruze M,. Simultaneous patch test sensitization to 4 chemically unrelated compounds in a standard test series. Contact Dermatitis 1984: 11: 48-49.
138. Estlander T, Kostiainen M, Jolanki R, Kanerva L,. Active sensitization and occupational allergic contact dermatitis caused by para-tertiary-butylcatechol. Contact Dermatitis 1998: 38: 96-100.
139. Kanerva L, Estlander T, Jolanki R,. Sensitization to patch test acrylates. Contact Dermatitis 1988: 18: 10-15.
140. Fonia A, White J M L, McFadden J P, White I R,. Active sensitization to chloracetamide. Contact Dermatitis 2009: 60: 58-59.
141. Wilkinson S M, Pollock B,. Patch test sensitization after use of the Compositae mix. Contact Dermatitis 1999: 40: 277-278.
142. Mose A P, Steenfeldt N, Andersen K E,. Flare-up of dermatitis following patch testing is more common in polysensitized patients. Contact Dermatitis 2010: 63: 289-290.
143. Uchida S, Oiso N, Matsunaga K, Kawada A,. Patch test reaction to p-phenylenediamine can persist for more than 1 month. Contact Dermatitis 2013: 69: 382-383.
144. Sperber B R, Allee J, Elenitsas R, James W D,. Papular dermatitis and a persistent patch test reaction to gold sodium thiosulfate. Contact Dermatitis 2003: 48: 204-208.
145. Thyssen J P, Johansen J D, Jellesen M S, Menné T,. Provocation test with metallic palladium in a palladium-allergic patient. Contact Dermatitis 2011: 65: 304-306.
146. Goossens A, De Swerdt A, De Coninck K, Snauwaert J E, Dedeurwaerder M, De Bonte M,. Allergic contact granuloma due to palladium following ear piercing. Contact Dermatitis 2006: 55: 338-341.
147. Curto L, Carnero L, Lõpez-Aventin D, Traveria G, Roura G, Giménez-Arnau A M,. Fast itch relief in an experimental model for methylprednisolone aceponate topical corticosteroid activity, based on allergic contact eczema to nickel sulphate. J Eur Acad Dermatol Venereol 2014: 28: 1356-1362.
148. Katta R,. Common misconceptions in contact dermatitis counseling. Dermatol Online J 2008: 14: 2.
149. Lidén C, Skare L, Nise G, Vahter M,. Deposition of nickel, chromium, and cobalt on the skin in some occupations - assessment by acid wipe sampling. Contact Dermatitis 2008: 58: 347-354.
150. Jensen P, Thyssen J P, Johansen J D, Skare L, Menné T, Lidén C,. Occupational hand eczema caused by nickel and evaluated by quantitative exposure assessment. Contact Dermatitis 2011: 64: 32-36.
151. Noiesen E, Munk M D, Larsen K, Johansen J D, Agner T,. Difficulties in avoiding exposure to allergens in cosmetics. Contact Dermatitis 2007: 57: 105-109.
152. Woo P N, Hay I C, Ormerod A D,. An audit of the value of patch testing and its effect on quality of life. Contact Dermatitis 2003: 48: 244-247.
153. Noiesen E, Larsen K, Agner T,. Compliance in contact allergy with focus on cosmetic labelling: a qualitative research project. Contact Dermatitis 2004: 51: 189-195.
154. Ho S G Y, Basketter D A, Jefferies D, Rycroft R J G, White I R, McFadden J P,. Analysis of para-phenylenediamine allergic patients in relation to strength of patch test reaction. Br J Dermatol 2005: 153: 364-367.
155. Vanneste L, Persson L, Zimerson E, Bruze M, Luyckx R, Goossens A,. Allergic contact dermatitis caused by methylisothiazolinone from different sources, including 'mislabelled' household wet wipes. Contact Dermatitis 2013: 69: 311-312.
156. Yiannias J, el Azhary R,. Contact Allergen Avoidance Program: a topical skin care product database. Am J Contact Dermat 2000: 11: 243-247.
157. Drieghe J, Goossens A,. On-line internet facilities for contact allergy software: CDESK/PRO. Contact Dermatitis 2002: 47: 243.
158. Zirwas M J,. Contact alternatives and the internet. Dermatitis 2012: 23: 192-194.
159. Lewis F M, Cork M J, McDonagh A J, Gawkrodger D J,. An audit of the value of patch testing: the patient's perspective. Contact Dermatitis 1994: 30: 214-216.
160. Scalf L A, Genebriera J, Davis M D P, Farmer S A, Yiannias J A,. Patients' perceptions of the usefulness and outcome of patch testing. J Am Acad Dermatol 2007: 56: 928-932.
161. Jamil W N, Erikssohn I, Lindberg M,. How well is the outcome of patch testing remembered by the patients? A 10-year follow-up of testing with the Swedish baseline series at the Department of Dermatology in Örebro, Sweden. Contact Dermatitis 2012: 66: 215-220.
162. Chowdhury M M U,. Draft: Cutaneous Allergy Post-CCT Curriculum 2014 Version 13, updated 4/12/2013: Wales, Cardiff & Vale University Health Board, 2014.
163. Adisesh A, Robinson E, Nicholson P J, Sen D, Wilkinson M,. UK standards of care for occupational contact dermatitis and occupational contact urticaria. Br J Dermatol 2013: 168: 1167-1175.
164. Uter W, Schnuch A, Giménez-Arnau A, Orton D, Statham B,. Databases and networks. The benefit for research and quality assurance in patch testing. In: Contact Dermatitis, 5th edition, Johansen, J. D.,;, Frosch, P. J., &, Lepoittevin, J.-P., (Eds): Heidelberg, Dordrecht, London, New York, Springer, 2011: 1053-1063.
165. Vigan M,. REVIDAL-GERDA: organization et collaboration avec la pharmacovigilance. Therapie 2002: 57: 263-264.
166. Lessmann H, Uter W, Geier J, Schnuch A,. Die Informations- und Dokumentationsstelle für Kontaktallergien (IDOK) des Informationsverbundes Dermatologischer Kliniken (IVDK). Dermatol Beruf Umwelt 2006: 54: 160-166.